Navigation Links
Avoiding secondhand smoke during pregnancy
Date:1/27/2009

San Diego, January 27, 2009 Environmental Tobacco Smoke (ETS) commonly called secondhand smoke, can harm a developing fetus and may account for complications during pregnancy and birth. It is now known that non-whites experience more adverse pregnancy effects than do whites from smoking and ETS exposure. In an article published in the March 2009 issue of the American Journal of Preventive Medicine, researchers examined whether black, non-smoking women were able to avoid ETS exposure early in pregnancy and the social contextual factors that affected their success in avoiding secondhand smoke.

This study was conducted by investigators from The George Washington University Medical Center School of Public Health & Health Services, Children's National Medical Center, RTI International, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Data were collected from 1044 women as part of a randomized, multiplerisk behavior intervention trial that addressed four risks for adverse pregnancy outcomes: cigarette smoking, ETS exposure, depression and intimate partner violence (IPV). In this study, the investigators analyzed data from 450 non-smokers who reported having partners, friends, household or family members who smoked. Demographic factors such as age, education, marital status and household income were collected, as was reproductive history information. Attitudes about being pregnant were assessed, as were mental health-related items such as depression symptoms and alcohol or illicit drug use. Interpersonal factors included having a current partner, the father's desire to have the baby and the incidence of IPV either before or during pregnancy.

Direct ETS exposure factors such as smoking by others in the household, household smoking bans, perceived support from significant others to avoid secondhand smoke and perceived harmfulness of ETS exposure to the baby's health were also measured. To accurately determine ETS exposure, cotinine levels in the mother's saliva were measured. Cotinine is a widely accepted biomarker for tobacco exposure.

Twenty-seven percent of pregnant nonsmokers were confirmed as ETS avoiders. The odds of ETS avoidance were increased among women who reported household smoking bans, reported the father wanted the baby and where no/few family members/friends smoked. The odds were decreased among women who had a current partner, reported any intimate partner violence during pregnancy and reported little social support to prevent ETS exposure.

Writing in the article, Susan Michele Blake, PhD, The George Washington University Medical Center, School of Public Health and Health Services, states, "Results highlight the importance of comprehensive prenatal screening to identify a woman's psychosocial and behavioral risks. Before addressing ETS exposure, it is important to gain a complete understanding of the social context of a woman's pregnancy. While providing behavioral counseling and skills-based interventions, it is important to consider other factors that could exacerbate risks for IPV and poor pregnancy outcomes."


'/>"/>

Contact: AJPM Editorial Office
eAJPM@ucsd.edu
858-457-7292
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. Complimentary Pamphlet on Avoiding Snow Blower Injuries Offered by Chicago Hospital
2. Avoiding a Holiday Season of Discontent
3. Immune molecule that plays a powerful role in avoiding organ rejection identified
4. U.S. Preventive Medicine Experts Available to Discuss Role of Prevention in Avoiding Heart Attacks
5. RF Technologies Assists Healthcare Providers in Avoiding Preventable Injury Conditions to be Denied Reimbursement by Medicare
6. Dietary oil may need help in avoiding any side effects of weight loss
7. Proper Hand Hygiene Is Key to Avoiding Illness During Cold and Flu Season
8. Almost Half of Kids Still Exposed to Secondhand Smoke
9. Secondhand smoke raises odds of fertility problems in women
10. Exposure to secondhand smoke reduced
11. Ft. Lauderdale Jury Awards Couple over $3 Million in Secondhand Asbestos Exposure Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... , ... August 20, 2017 , ... ... HIPAA ComplyPAK™ Compliance Management System has assisted multiple clients in successfully ... Public Accountants, Service Organization Control Level 2 (AICPA SOC Level 2), and State ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... will feature the Aurum Group in an upcoming episode, slated to air fourth ... Innovations will feature the Aurum Group; a company committed to supporting dentistry using ...
(Date:8/19/2017)... ... August 18, 2017 , ... ... Act of 2017, legislation that provides for greater public access to over-the-counter (OTC) ... loss to access OTC hearing aids without being seen by a certified and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has launched a ... show the diversity of the breastfeeding mothers, using bright colors and contemporary ... These illustrations are also available on tote bags, notepads, smartphone cases, clocks, and ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician ... its Orlando location as an interventional pain management physician. He brings a wealth ... treatment of migraine headaches, and significant experience in spinal cord stimulation for chronic ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Saban as president, effective Aug. 7, 2017. ... decided to pursue other interests and will serve as president ... Paul has served us in multiple leadership roles since he ... Jun. 2015 and has provided decisive, strategic leadership which continues ...
(Date:8/7/2017)... 2017  Endo International plc (NASDAQ: ENDP ... virtually all known U.S. mesh product liability claims and ... known remaining U.S. claims at reasonable values. Under the ... fourth quarter of 2017 and continuing through the fourth ... 2017 results, the Company intends to increase its mesh ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
Breaking Medicine Technology: